Biotech

Portfolio

Lists

Sources

Guide

8.0

Axial

9.0

Borlaug’s Substack

8.5

BowTiedBiotech

9.0

Breaking Biotech

9.0

Jonathan Faison

9.0

Matt Gamber’s Biotech Newsletter

9.0

The Century of Biology

8.0

Turning Rough Stones

BowTiedBiotech

Your Weekly Biotech News Fix | Ep. 694

June 6, 2025, 4 p.m.

Some Paywall

BowTiedBiotech

Stalled at the Gate | Ep. 693

June 5, 2025, 10:33 p.m.

Some Paywall

BowTiedBiotech

The Radiopharma Renaissance | Ep. 692

June 4, 2025, 12:22 p.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

Replimune Has Significant Upside Potential, When Approved. But When Will That Be?

June 2, 2025, 11:01 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $FATE | Ep. 690

June 2, 2025, 9:30 a.m.

Some Paywall

Turning Rough Stones

Chesapeake Financial Shares (CPKF): Cheap based on forward P/E and adjusted book value

June 1, 2025, 1:16 p.m.

No Paywall

BowTiedBiotech

Pan-Tumor is the Future | Ep. 689

June 1, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Weekly Biotech News Update | Ep.688

May 31, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Your Weekly Biotech News Fix | Ep. 687

May 30, 2025, 4:02 p.m.

Some Paywall

BowTiedBiotech

Biotech is Crowded | Ep. 686

May 29, 2025, 10:06 p.m.

Some Paywall

BowTiedBiotech

Exploring the Transition from Founder to Traditional CEO | Ep. 685

May 28, 2025, 12:31 p.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

TG Therapeutics Should Increase Their Share Buyback Authorization Immediately

May 27, 2025, 11:03 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $SRRK | Ep. 684

May 26, 2025, 9:30 a.m.

Some Paywall

BowTiedBiotech

The Oral Peptide Revolution | Ep. 683

May 25, 2025, 4:01 p.m.

Some Paywall

BowTiedBiotech

Weekly Biotech News Fix | Ep. 682

May 24, 2025, 10:11 p.m.

Some Paywall

BowTiedBiotech

Your Weekly Biotech News Fix | Ep. 681

May 23, 2025, 4:01 p.m.

Some Paywall

BowTiedBiotech

Biotech's Split Screen | Ep. 680

May 22, 2025, 10:06 p.m.

Some Paywall

Jonathan Faison

scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025

May 22, 2025, 11:29 a.m.

Paywall

BowTiedBiotech

How VCs Are Adapting to a Changing Market | Ep. 679

May 21, 2025, 11:31 a.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

Commercial-Stage Biotech Is Undervalued. Q1 Earnings Recap, Part 2.

May 19, 2025, 11:03 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $URGN | Ep. 677

May 19, 2025, 9:30 a.m.

Some Paywall

BowTiedBiotech

Biotech Salaries Are Rising | Ep. 676

May 18, 2025, 4:01 p.m.

Some Paywall

BowTiedBiotech

Your Weekly Biotech News Fix | Ep. 675

May 17, 2025, 12:23 p.m.

Some Paywall

BowTiedBiotech

Your Weekly Biotech News Fix | Ep. 674

May 16, 2025, 4:01 p.m.

Some Paywall

BowTiedBiotech

The MFN Threat | Ep. 673

May 15, 2025, 9:34 p.m.

Some Paywall

BowTiedBiotech

The State of B-Cell Depletion Therapies | Ep. 672

May 14, 2025, 12:22 p.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

Who's Raising Full Year Guidance? Who's Affirming Full Year Guidance? Q1 Earnings Recap, Part 1.

May 12, 2025, 11:03 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $ANNX | Ep. 670

May 12, 2025, 9:30 a.m.

Some Paywall

BowTiedBiotech

The IRA’s Silent Kill Switch | Ep. 669

May 11, 2025, 2:11 p.m.

Some Paywall

BowTiedBiotech

Weekly Biotech News Fix | Ep. 668

May 10, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Sweat Equity - Your Weekly Biotech News Fix | Ep. 667

May 9, 2025, 4:02 p.m.

Some Paywall

BowTiedBiotech

Syndicate Signals | Ep. 666

May 8, 2025, 10:33 p.m.

Some Paywall

BowTiedBiotech

The Hottest Ticket in Town | Ep. 665

May 7, 2025, 11:05 a.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

Earnings Calendar For This Week, Near-Term Clinical Catalysts, YTD Performance, And More...

May 5, 2025, 11:02 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $CNTA | Ep. 663

May 5, 2025, 9:30 a.m.

Some Paywall

BowTiedBiotech

Venture Capital’s Game of Inches | Ep. 662

May 4, 2025, 12:31 p.m.

Some Paywall

Axial

Inventors

May 3, 2025, 7:56 p.m.

Some Paywall

BowTiedBiotech

Weekly Biotech News Fix | Ep.661

May 3, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Your Weekly Biotech News Fix | Ep. 660

May 2, 2025, 4 p.m.

Some Paywall

BowTiedBiotech

Pharma’s Topline Cliff and the Coming Biotech Buyout Wave | Ep. 659

May 1, 2025, 10:33 p.m.

Some Paywall

BowTiedBiotech

Dual-Payload ADCs | Ep. 658

April 30, 2025, 11:32 a.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

Q1 Earnings Season Preview: Commercial-Stage Biotechs

April 28, 2025, 11:02 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $CRVS | Ep. 656

April 28, 2025, 9:30 a.m.

Some Paywall

BowTiedBiotech

The Future of Immuno-Oncology | Ep. 655

April 27, 2025, 4 p.m.

Some Paywall

BowTiedBiotech

Your Weekly Biotech News Fix | Ep. 654

April 26, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Sweat Equity - Your Weekly Biotech News Fix | Ep. 653

April 25, 2025, 12:28 p.m.

Some Paywall

BowTiedBiotech

The Biotech Bottom, Bessent Backstop & Defensive Investing | Ep. 652

April 24, 2025, 10:42 p.m.

Some Paywall

BowTiedBiotech

PLAUSIBLE MECHANISM, PLAUSIBLE PROFIT | Ep. 651

April 23, 2025, 11:01 a.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

Short sellers are confident Cardiff Oncology will underwhelm - but are they right?

April 21, 2025, 11:02 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $CMPS | Ep. 649

April 21, 2025, 9:30 a.m.

Some Paywall

1 - 50 of 1528 Results

2 3

No commentary found!

No news content found!

Add to your lists

Recommended Content

Biotech